In Vitro Diagnostics | Medtech 360 | Market Analysis | US | 2019
The US market for IVDs will exhibit moderate growth through 2027, driven by the aging US population and the shift toward value-based health care, which will fuel uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IVDs in the US across a 10-year period.